X0306 4 2018-02-26 0 0001077183 NEOGENOMICS INC NEO 0001640500 BALLIET JENNIFER 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913 0 1 0 0 VP and Chief Culture Officer Stock Option (Right to Buy) 4.78 2016-05-04 2020-05-04 Common Stock 120000 120000 D Stock Option (Right to Buy) 7.15 2017-04-20 2021-04-20 Common Stock 50000 50000 D Stock Option (Right to Buy) 7.52 2018-04-28 2022-04-28 Common Stock 60000 60000 D Restricted Stock 0.00 2018-05-25 Common Stock 20000 20000 D Stock Option (Right to Buy) 8.03 2018-02-26 4 A 0 72500 8.03 A 2019-02-26 2023-02-26 Common Stock 72500 72500 D On May 4, 2015, Jennifer Balliet was granted 120,000 stock options. The options vest ratably over the first three anniversary dates of the grant date. On April 20, 2016, Jennifer Balliet was granted 50,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. On April 28, 2017, Jennifer Balliet was granted 60,000 stock options. The options vest ratably over the first three anniversaries of the grant date. Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. Restricted stock will vest as follows; 6,666 units will vest on May 25, 2018 and 6,667 units will vest on May 25, 2019 and 2020. These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date. On February 26, 2018, Jennifer Balliet was granted 72,500 stock options which vested ratably over the first three anniversary dates of the grant date. /s/Jennifer Balliet 2018-02-28